Literature DB >> 10076627

Identification of Leptospira biflexa by real-time homogeneous detection of rapid cycle PCR product.

T H Woo1, B K Patel, M Cinco, L D Smythe, M A Norris, M L Symonds, M F Dohnt, J Piispanen.   

Abstract

Sequence analysis of 16S rRNA genes extracted from nucleic acids databases enabled the identification of a Leptospira biflexa (L. biflexa) signature sequence, against which a reverse primer designated L613, was designed. This primer, when used in conjunction with a universal bacterial specific forward primer designated Fd1, enabled the development of a LightCycler-based PCR protocol in which fluorescence emission due to binding of SYBR Green I dye to amplified products could be detected and monitored. A melting temperature (Tm), determined from the melting curve of the amplified product immediately following the termination of thermal cycling, confirmed that the product was that of L. biflexa. Agarose gel electrophoresis therefore was not necessary for identification of PCR products. The PCR protocol was very rapid, and consisted of 30 cycles with a duration of 20 s for each cycle with the monitoring of the melting curve requiring an additional 3 min. The whole protocol was completed in less than 20 min. The PCR protocol was also specific and enabled the identification of 18 strains of L. biflexa, whilst excluding 14 strains of L. interrogans and Leptonema illini. Two examples of its utility in improving work flow of a Leptospira reference laboratory are presented in this article. The use of a simple boiling method for extraction of DNA from all the members of the Leptospiraceae family DNA further simplifies the procedure and makes its use conducive to diagnostic laboratories.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076627     DOI: 10.1016/s0167-7012(98)00095-5

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  6 in total

1.  Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium.

Authors:  David E Buchholz; Britney O Pennington; Roxanne H Croze; Cassidy R Hinman; Peter J Coffey; Dennis O Clegg
Journal:  Stem Cells Transl Med       Date:  2013-04-18       Impact factor: 6.940

2.  Real-time PCR for detection and quantitation of leishmania in mouse tissues.

Authors:  Luc Nicolas; Eric Prina; Thierry Lang; Geneviève Milon
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.

Authors:  Gregory S Hageman; Lisa S Hancox; Andrew J Taiber; Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Monte J Radeke; David Kavanagh; Anna Richards; John Atkinson; Seppo Meri; Julie Bergeron; Jana Zernant; Joanna Merriam; Bert Gold; Rando Allikmets; Michael Dean
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

Review 4.  The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.

Authors:  Don H Anderson; Monte J Radeke; Natasha B Gallo; Ethan A Chapin; Patrick T Johnson; Christy R Curletti; Lisa S Hancox; Jane Hu; Jessica N Ebright; Goldis Malek; Michael A Hauser; Catherine Bowes Rickman; Dean Bok; Gregory S Hageman; Lincoln V Johnson
Journal:  Prog Retin Eye Res       Date:  2009-12-02       Impact factor: 21.198

5.  Expression profiles of nestin and synemin in reactive astrocytes and Müller cells following retinal injury: a comparison with glial fibrillar acidic protein and vimentin.

Authors:  Gabriel Luna; Geoffrey P Lewis; Christopher D Banna; Omar Skalli; Steven K Fisher
Journal:  Mol Vis       Date:  2010-11-27       Impact factor: 2.367

6.  Targeted Gene Candidates for Treatment and Early Diagnosis of Age-Related Macular Degeneration.

Authors:  Emine Cinici; Ozge Caglar; Mehmet Enes Arslan; Nilay Dilekmen; Bahadır Utlu; Adil Mardinoglu; Hasan Turkez
Journal:  Biomed Res Int       Date:  2021-02-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.